Higher levels of everyday ageism associated with increased risk for negative physical and mental health outcomes

Risks for new-onset psychiatric diagnoses and anxiety disorders, but not mood disorders, increased in early postacute phase

Percent of patients with conditions that had substantial or conclusive evidence of therapeutic value decreased from 2016 to 2020